Skip to main content
Livermore
Livermore
ZHEN

Centessa Pharmaceuticals plc

CNTADelisted Jun 24, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001847903

Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.

13F holders, Q4 2021

Institutional positions in Centessa Pharmaceuticals plc as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
47
+7 vs. Q3 2021
Shares held
71.9M
+15.0M (+26.3%) vs. Q3 2021
Total value
$807.8M
−$139.7M (−14.7%) vs. Q3 2021
New holders
15
19 more added
Sold out
8
7 more reduced

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CNTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 47 institutions
Q1 2021: 0 institutionsQ2 2021: 50 institutionsQ3 2021: 40 institutionsQ4 2021: 47 institutionsQ1 2022: 44 institutionsQ2 2022: 41 institutionsQ3 2022: 44 institutionsQ4 2022: 44 institutionsQ1 2023: 44 institutionsQ2 2023: 45 institutionsQ3 2023: 49 institutionsQ4 2023: 58 institutionsQ1 2024: 69 institutionsQ2 2024: 80 institutionsQ3 2024: 103 institutionsQ4 2024: 114 institutionsQ1 2025: 130 institutionsQ2 2025: 117 institutionsQ3 2025: 125 institutionsQ4 2025: 147 institutionsQ1 2026: 161 institutionsQ2 2026: 0 institutions
Value heldQ4 2021: $807.8M
Q1 2021: $0Q2 2021: $1.05BQ3 2021: $947.5MQ4 2021: $807.8MQ1 2022: $669.1MQ2 2022: $350.3MQ3 2022: $288.7MQ4 2022: $194.4MQ1 2023: $257.5MQ2 2023: $435.4MQ3 2023: $469.6MQ4 2023: $567.4MQ1 2024: $840.7MQ2 2024: $781.2MQ3 2024: $1.74BQ4 2024: $2.08BQ1 2025: $1.80BQ2 2025: $1.62BQ3 2025: $3.11BQ4 2025: $3.60BQ1 2026: $5.90BQ2 2026: $0
Institutions holding CNTA and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 2026161$5.90B
Q4 2025147$3.60B
Q3 2025125$3.11B
Q2 2025117$1.62B
Q1 2025130$1.80B
Q4 2024114$2.08B
Q3 2024103$1.74B
Q2 202480$781.2M
Q1 202469$840.7M
Q4 202358$567.4M
Q3 202349$469.6M
Q2 202345$435.4M
Q1 202344$257.5M
Q4 202244$194.4M
Q3 202244$288.7M
Q2 202241$350.3M
Q1 202244$669.1M
Q4 202147$807.8M
Q3 202140$947.5M
Q2 202150$1.05B
Q1 20210$0

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Centessa Pharmaceuticals plc; share changes are against Q3 2021.

Institutions holding CNTA in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
State of Wyoming61$1.00K0.00%+38+165.2%Added
Adirondack Trust Co400$5.00K0.00%+400New
UBS Group AG496$6.00K0.00%+275+124.4%Added
Cubist Systematic Strategies, LLC632$7.00K0.00%+432+216.0%Added
Advisor Group Holdings, Inc.750$9.00K0.00%+750New
Tower Research Capital LLC (TRC)930$10.0K0.00%+811+681.5%Added
Citigroup Inc1,029$12.0K0.00%+820+392.3%Added
JPMorgan Chase & Co4,509$51.0K0.00%+2,681+146.7%Added
Compagnie Lombard Odier SCmA5,820$66.0K0.00%+3,070+111.6%Added
Northern Trust Corp8,884$100.0K0.00%+8,884New
Gyon Technologies Capital Management, LP10,426$117.0K0.02%+10,426New
Golden State Equity Partners13,870$156.0K0.08%+13,870New
Morgan Stanley14,085$158.0K0.00%+6,455+84.6%Added
Virtus ETF Advisers LLC14,798$167.0K0.06%+14,798New
Nan Fung Group Holdings Ltd22,200$250.0K0.07%+22,200New
TD Asset Management Inc33,252$374.0K0.00%00.0%Unchanged
Verition Fund Management LLC50,000$563.0K0.01%+50,000New
Bank of America Corp79,245$892.0K0.00%+76,446+2,731.2%Added
FMR LLC94,300$1.06M0.00%−268,437−74.0%Reduced
Kynam Capital Management, LP239,041$2.69M1.44%+239,041New
BlackRock Inc.287,238$3.23M0.00%+287,238New
Citadel Advisors LLC340,065$3.83M0.00%−9,483−2.7%Reduced
Ensign Peak Advisors, Inc343,292$3.87M0.01%+56,888+19.9%Added
Deep Track Capital, LP400,000$4.50M0.33%+400,000New
Affinity Asset Advisors, LLC419,144$4.72M2.01%+215,961+106.3%Added
Logos Global Management LP454,545$5.12M0.53%−615,000−57.5%Reduced
BVF Inc454,545$5.12M0.19%+454,545New
American Century Companies Inc517,123$5.82M0.00%+146,831+39.7%Added
Franklin Resources Inc575,538$6.48M0.00%−346,562−37.6%Reduced
Wellington Management Group LLP727,273$8.19M0.00%+727,273New
Woodline Partners LP801,136$9.02M0.13%−81,677−9.3%Reduced
EcoR1 Capital, LLC882,176$9.93M0.32%+127,631+16.9%Added
Driehaus Capital Management LLC1,085,697$12.2M0.12%+66,897+6.6%Added
Point72 Asset Management, L.P.1,097,908$12.4M0.05%+795,708+263.3%Added
Baker Bros. Advisors LP1,127,273$12.7M0.06%00.0%Unchanged
VR Adviser, LLC1,127,272$12.7M1.74%00.0%Unchanged
Boxer Capital, LLC1,251,137$14.1M0.56%−83,090−6.2%Reduced
Samsara BioCapital, LLC1,459,693$16.4M3.27%−77,840−5.1%Reduced
Price T Rowe Associates Inc2,076,770$23.4M0.00%+58,897+2.9%Added
OUP Management Co., LLC2,341,891$26.4M11.89%+2,341,891New
Cormorant Asset Management, LP2,489,894$28.0M1.67%+762,621+44.2%Added
Ra Capital Management, L.P.3,577,094$40.3M0.71%00.0%Unchanged
Vida Ventures Advisors, LLC3,931,818$44.3M16.56%00.0%Unchanged
Janus Henderson Group PLC5,743,397$63.1M0.03%+136,095+2.4%Added
General Atlantic LLC9,681,818$109.0M0.84%00.0%Unchanged
Index Venture Life Associates VI Ltd9,961,789$112.2M100.00%+9,961,789New
Medicxi Ventures Management (Jersey) Ltd18,123,892$204.1M51.07%+200,000+1.1%Added
Millennium Management LLC0$00.00%−337,002−100.0%Sold out
Jennison Associates LLC0$00.00%−296,456−100.0%Sold out
Caas Capital Management LP0$00.00%−62,500−100.0%Sold out
Brookfield Asset Management Inc.0$00.00%−26,788−100.0%Sold out
Ghisallo Capital Management LLC0$00.00%−15,000−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−12,420−100.0%Sold out
Royal Bank of Canada0$00.00%−453−100.0%Sold out
Evolution Wealth Advisors, LLC0$00.00%−160−100.0%Sold out